Injectafer (ferric carboxymaltose) is a prescription drug that’s used to treat anemia caused by low iron levels. The drug comes as an injectable solution that’s given by injection or infusion. It’s ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ -- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from that spring 2018 medical visit suggested ...
The pharmaceutical drug Injectafer (generic name: ferric carboxymaltose), an iron carbohydrate complex used to treat iron deficiency anemia, has been linked to severe hypophosphatemia (HPP) – a ...
Injectafer (ferric carboxymaltose) is a brand-name drug that’s prescribed for iron deficiency anemia in adults and some children. Injectafer comes as a liquid solution that’s given by a healthcare ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results